Pharmanutra S.p.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 23.73 million compared to EUR 23.61 million a year ago. Revenue was EUR 24.04 million compared to EUR 23.78 million a year ago.

Net income was EUR 2.63 million compared to EUR 4.64 million a year ago. Basic earnings per share from continuing operations was EUR 0.27 compared to EUR 0.48 a year ago.